NEW YORK (Reuters Health) – Both obesity and type 2 diabetes, owing to their harmful effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in…
NEW YORK (Reuters Health) – Celiac disease is 4 times more common now than it was in the 1950’s, according to researchers at the Mayo Clinic in Rochester,…
NEW YORK (Reuters Health) – Serial measurement of blood urea nitrogen (BUN) provides the most valuable prognostic information of six routinely collected admission laboratory tests in patients admitted…
NEW YORK (Reuters Health) – As plasma levels of adiponectin, a protein produced by fat cells, rise, the risk of type 2 diabetes decreases, according to the results…
NEW YORK (Reuters Health) – Treatment of cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) by loop electrosurgical excision (LEEP) may lead to a reduction in acquisition of…
NEW YORK (Reuters Health) – C-reactive protein (CRP) does not appear to have a causal role in coronary heart disease (CHD), and using it to predict the risk…
NEW YORK (Reuters Health) – Sperm washing and in-vitro fertilization (IVF) with intracytoplasmic sperm infection (ICSI) can safely achieve pregnancy in couples in which the male is HIV-positive,…
NEW YORK (Reuters Health) – Urine testing for leucine-rich alpha-2-glycoprotein and other biomarkers may improve the ability of doctors to diagnose acute appendicitis, according to a report in…
NEW YORK (Reuters Health) – Biomarkers of systemic inflammation are independent predictors of mortality, cardiovascular events, and amputation-free survival in patients undergoing lower extremity revascularization (LER), new research…
CHICAGO (Reuters Health) – A Canadian study of patients with inflammatory bowel disease (IBD) shows that they are 42% more likely to acquire methicillin-resistant Staphylococcus aureus (MRSA) infections…
